Zhangzhou Pientzehuang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Zhangzhou Pientzehuang Pharmaceutical has a total shareholder equity of CN¥14.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are CN¥17.0B and CN¥2.8B respectively. Zhangzhou Pientzehuang Pharmaceutical's EBIT is CN¥3.4B making its interest coverage ratio -26. It has cash and short-term investments of CN¥9.2B.
Key information
7.5%
Debt to equity ratio
CN¥1.07b
Debt
| Interest coverage ratio | -26x |
| Cash | CN¥9.20b |
| Equity | CN¥14.24b |
| Total liabilities | CN¥2.80b |
| Total assets | CN¥17.05b |
Recent financial health updates
Recent updates
Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)
Sep 08
Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts
Aug 20Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price
Jul 12These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
May 27Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price
Feb 28Financial Position Analysis
Short Term Liabilities: 600436's short term assets (CN¥15.1B) exceed its short term liabilities (CN¥2.5B).
Long Term Liabilities: 600436's short term assets (CN¥15.1B) exceed its long term liabilities (CN¥275.1M).
Debt to Equity History and Analysis
Debt Level: 600436 has more cash than its total debt.
Reducing Debt: 600436's debt to equity ratio has reduced from 11.8% to 7.5% over the past 5 years.
Debt Coverage: 600436's debt is well covered by operating cash flow (113.7%).
Interest Coverage: 600436 earns more interest than it pays, so coverage of interest payments is not a concern.